Gain Therapeutics Inc. (GANX)

Sector:NA
Super Investor Stats:
Ownership count:1
Ownership rank:662
% of all portfolios:0.001%
History Portfolio Manager Activity Share change % change to portfolio
Q1  2024
David Einhorn - Greenlight Capital Reduce 3.79% 22,280 0.00
Q3  2023
David Einhorn - Greenlight Capital Add 7.66% 41,850 0.01
Q1  2021
David Einhorn - Greenlight Capital Buy 546,560 0.57

* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.